FMP

FMP

Enter

CNCE - Concert Pharmaceuticals, Inc.

Profile of Concert Pharmaceuticals, Inc.(CNCE), Concert Pharmaceuticals, Inc. operates as a clinical stage biopharmaceutical company that develops n

About

ceo

Dr. Roger D. Tung Ph.D.

sector

Healthcare

industry

Biotechnology

website

https://www.concertpharma.com

exchange

NASDAQ

Description

Concert Pharmaceuticals, Inc. operates as a clinical stage biopharmaceutical company that develops novel small molecule drugs for the treatment of autoimmune diseases. The company's lead product candidate is CTP-543, which is in Phase III clinical trial for the treatment of alopecia areata, a serious autoimmune dermatological condition. It has strategic collaborations with Avanir Pharmaceuticals, Inc.; Jazz Pharmaceuticals, Inc.; Cipla Technologies; and Processa Pharmaceuticals. The company was incorporated in 2006 and is headquartered in Lexington, Massachusetts.

CIK

0001367920

ISIN

US2060221056

CUSIP

206022105

Address

65 Hayden Avenue

Phone

781 860 0045

Country

US

Employee

64

IPO Date

Feb 13, 2014

Key Executives

page loading card
FMP

FMP

Financial Modeling Prep API provides real time stock price, company financial statements, major index prices, stock historical data, forex real time rate and cryptocurrencies. Financial Modeling Prep stock price API is in real time, the company reports can be found in quarter or annual format, and goes back 30 years in history.
twitterlinkedinfacebookinstagram
2017-2024 © Financial Modeling Prep